← Back to Search

Software

Opportunistic screening for low BMD for Osteoporosis

N/A
Recruiting
Led By Anastasia Oikonomou, MD, PhD
Research Sponsored by 16 Bit Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 9 months
Awards & highlights

Study Summary

This trial will assess the ability of a software, RhoTM, to accurately identify patients with low bone mineral density (BMD). RhoTM is designed as a pre-screening tool for osteoporosis, a disease characterized by loss of BMD. The trial will analyze the performance and impact of RhoTM in real-world settings.

Eligible Conditions
  • Osteoporosis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~9 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 9 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Positive predictive value
Secondary outcome measures
DXA conversion
Other outcome measures
Fracture risk assessment tool (FRAX) scores
Radiologist adoption

Trial Design

1Treatment groups
Experimental Treatment
Group I: Opportunistic screening for low BMDExperimental Treatment1 Intervention
Outpatients aged over 50 years undergoing x-ray of the thoracic spine, lumbar spine, chest, pelvis, hand or knee will have their x-rays screened for low BMD by the software-as-a-medical device. If low BMD is identified by the software, a radiologist reviewing the x-ray may choose to incorporate this as an incidental finding in their report to the referring physician.

Find a Location

Who is running the clinical trial?

Sunnybrook Health Sciences CentreOTHER
656 Previous Clinical Trials
1,549,422 Total Patients Enrolled
2 Trials studying Osteoporosis
440 Patients Enrolled for Osteoporosis
AmgenIndustry Sponsor
1,370 Previous Clinical Trials
1,376,488 Total Patients Enrolled
55 Trials studying Osteoporosis
550,673 Patients Enrolled for Osteoporosis
16 Bit Inc.Lead Sponsor

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there still openings available to join this medical experiment?

"According to clinicaltrials.gov, this trial is not presently enlisting patients. Originally posted on September 1st 2022 and last edited July 13th 2022, it has currently ceased recruitment though there are 40 other studies that need participants at this time."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Clinical Deployment and Validation of Rho
2022. "Clinical Deployment and Validation of Rho". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05245851.
~497 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top